Invezz
Dyne Therapeutics Announces Key Leadership Appointments | Invezz
Doug Kerr, M.D., Ph.D., MBA, has been appointed chief medical officer (CMO) succeeding Wildon Farwell, M.D., MPH, who is stepping down from his role and will remain at Dyne full-time through ...
4 days ago